Curaleaf Holdings, Inc. (CURLF) Financials

CURLF Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 2.8 billion 1.9 billion
Dec. 31, 2025 2.8 billion 2.0 billion
Sept. 30, 2025 2.9 billion 2.0 billion
June 30, 2025 2.9 billion 2.0 billion

CURLF Free Cash Flow and Stock based compensation

No data available :(

CURLF Net Income

No data available :(

CURLF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 106.5 million 526.8 million 434.4 million
Dec. 31, 2025 101.4 million 512.0 million 448.9 million
Sept. 30, 2025 92.8 million 500.0 million 279.7 million
June 30, 2025 102.5 million 512.3 million 282.0 million

CURLF Shares Outstanding

No data available :(

CURLF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 16.7 million - 121.2 million -
Dec. 31, 2025 15.8 million - 125.4 million -
Sept. 30, 2025 16.4 million 261000 116.5 million 12.3 million
June 30, 2025 15.3 million 261234 115.3 million -

CURLF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 319.7 million 197.8 million
Dec. 31, 2025 338.2 million 209.8 million
Sept. 30, 2025 320.2 million 160.5 million
June 30, 2025 319.7 million 200.8 million

CURLF

Price: $9.33

52 week price:
2.16
15.15

Earnings Per Share: -0.36 USD

P/E Ratio: -6.33

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 2.6 billion

Links: